Tag: screening

A British clinical trial and new Italian study highlight how pairing MRI with PSA density could change prostate cancer detection. By refining who needs biopsy, this method offers earlier diagnosis of significant cancers while avoiding unnecessary procedures. keep reading

The use of 2 parameters of imaging sequences is called biparametric MRI (bpMRI) – and new research shows it could make MRI widely available as a better screening tool than the PSA test which can lead to overdiagnosis and overtreatment. Now there’s an exciting boost to the speed and accuracy of bpMRI: Deep Learning (DL), a branch of Artificial Intelligence (AI). keep reading

Researchers are advancing smarter prostate cancer screening methods. A new biomarker test, combined with advanced MRI techniques, could improve early detection of high-grade prostate cancers and reduce the need for unnecessary procedures, offering more accurate and reliable diagnosis. keep reading

“Those who cannot remember the past are condemned to repeat it,” said the 20th century philosopher George Santayana. Though he wasn’t referring family heredity, we might rephrase his words as follows: Those who ignore a family history of cancer are condemned to a higher risk of developing it. That’s because cancer has many genetic properties keep reading

How many men put off getting a physical because of the digital rectal exam (DRE)? While the DRE has comic value in movie and TV scenes (the doctor snaps on a rubber glove while the man on the table looks like he’d rather walk on hot coals), a question circulating among urologists and primary care doctors is whether it still has screening value... keep reading

Does PSA screening reduce PCa mortality, or doesn’t it? We know that PSA is not specific for cancer, since many prostate conditions can cause a rise in PSA blood levels. We also know that an elevated PSA can lead to a conventional TRUS-guided biopsy, and that such biopsies can either miss prostate cancer or... keep reading

It’s hard to believe it’s been nearly 10 years since the U.S. Preventive Services Task Force stirred up controversy by recommending against routine PSA screening. They were concerned about overdiagnosis and overtreatment due to the nonspecific nature of an elevated PSA. Overreacting (if it can be called that) is potentially costly... keep reading

No doubt you are aware that many toxic substances are associated with higher cancer risk, and when there’s definite evidence of causing cancer, they are called carcinogens. For example, several national and international bodies have linked Agent Orange with prostate cancer (PCa) and numerous other cancers or cancer precursors. However, there are studies that suggest keep reading

“I can’t afford it.” Unless you’re an impulse buyer, no matter how attractive a purchase looks you’re going to take the cost into account. Will your budget accommodate your desire? Of course, there strategies that can bring you closer to getting what you want. For example, you can: Shop around and compare prices for the keep reading

Prostate cancer (PCa) is the most common non-skin cancer in men, and it’s one of the most curable if it’s detected early. In addition, the American Cancer Society points out, “Catching cancer early often allows for more treatment options.” This is definitely true for PCa, since the number of available treatment methods has grown in keep reading